Home Blog Page 2

Investing in ENDRA Life Sciences Inc. (NDRA): What You Must Know

0

ENDRA Life Sciences Inc.’s filing revealed that its Director Tokman Alexander Y acquired Company’s shares for reported $1700.0 on Nov 23. In the deal valued at $0.17 per share,10,000 shares were bought. As a result of this transaction, Tokman Alexander Y now holds 162,857 shares worth roughly $27685.690000000002.

Then, Thornton Michael Milos bought 20,000 shares, generating $5,400 in total proceeds. Upon buying the shares at $0.27, the Chief Technology Officer now owns 352,775 shares.

Before that, Tokman Alexander Y bought 20,000 shares. ENDRA Life Sciences Inc. shares valued at $5,200 were divested by the Director at a price of $0.26 per share. As a result of the transaction, Tokman Alexander Y now holds 152,857 shares, worth roughly $25985.690000000002.

Price Performance Review of NDRA

On Monday, ENDRA Life Sciences Inc. [NASDAQ:NDRA] saw its stock fall -12.10% to $0.17. On the same session, the stock had its day’s lowest price of $0.1747, but rose to a high of $0.1973. Over the last five days, the stock has gained 2.40%. ENDRA Life Sciences Inc. shares have fallen nearly -74.70% since the year began. Nevertheless, the stocks have fallen -78.01% over the past one year. While a 52-week high of $0.93 was reached on 01/06/22, a 52-week low of $0.16 was recorded on 11/28/22. SMA at 50 days reached $0.2521, while 200 days put it at $0.2872. A total of 0.53 million shares were traded, compared to the trading of 0.21 million shares in the previous session.

Levels Of Support And Resistance For NDRA Stock

The 24-hour chart illustrates a support level at 0.1674, which if violated will result in even more drops to 0.1597. On the upside, there is a resistance level at 0.1900. A further resistance level may holdings at 0.2049. The Relative Strength Index (RSI) on the 14-day chart is 37.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0069, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.33%. Stochastics %K at 29.57% indicates the stock is a holding.

How much short interest is there in ENDRA Life Sciences Inc.?

A steep rise in short interest was recorded in ENDRA Life Sciences Inc. stocks on Oct 13, 2022, dropping by 89700.0 shares to a total of 0.68 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 0.77 million shares. There was a decline of -13.1%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.10% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.18.

ENDRA Life Sciences Inc. [NDRA] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 980,583 shares, or roughly 1.55% of the outstanding NDRA shares. In other words, the investor’s shares have fallen by -174,225 from its previous 13-F filing of 1154808.0. Additionally, Morgan Stanley & Co. LLC increased 1.66% of its stake after which the total value it holdings stand at $197,326. At present, Incrementum AG is holding 168,887 shares valued at $38844.0. SSgA Funds Management, Inc. owned 105,691 shares of the company at the time of its most recent 13F filing, worth $24309.0.

Unity Software Inc. [U] stock was sold by Downie Clive at the price of US$0.51 million

0

Unity Software Inc.’s recently made public that its SVP & GM, Consumer Downie Clive unloaded Company’s shares for reported $0.51 million on Nov 28. In the deal valued at $35.70 per share,14,221 shares were sold. As a result of this transaction, Downie Clive now holds 196,821 shares worth roughly $7.49 million.

Then, Visoso Luis Felipe sold 16,483 shares, generating $588,278 in total proceeds. Upon selling the shares at $35.69, the SVP and CFO now owns 737,715 shares.

Before that, Whitten Marc sold 11,853 shares. Unity Software Inc. shares valued at $423,034 were divested by the SVP & GM, Create Solutions at a price of $35.69 per share. As a result of the transaction, Whitten Marc now holds 680,838 shares, worth roughly $25.93 million.

PT values the company’s stock at a premium of -38.47 to its Monday closing price. Piper Sandler also remained covering U and has increased its forecast on October 28, 2022 with a “an Overweight” recommendation from previously “Neutral” rating. Needham started covering the stock on October 07, 2022. It rated U as “a Buy”.

Price Performance Review of U

On Monday, Unity Software Inc. [NYSE:U] saw its stock fall -6.99% to $38.08. On the same session, the stock had its day’s lowest price of $38.00, but rose to a high of $42.19. Over the last five days, the stock has gained 7.24%. Unity Software Inc. shares have fallen nearly -73.37% since the year began. Nevertheless, the stocks have fallen -74.07% over the past one year. While a 52-week high of $157.48 was reached on 01/03/22, a 52-week low of $21.22 was recorded on 11/09/22. SMA at 50 days reached $31.84, while 200 days put it at $51.51. A total of 11.9 million shares were traded, compared to the trading of 13.56 million shares in the previous session.

Levels Of Support And Resistance For U Stock

The 24-hour chart illustrates a support level at 36.66, which if violated will result in even more drops to 35.23. On the upside, there is a resistance level at 40.85. A further resistance level may holdings at 43.61. The Relative Strength Index (RSI) on the 14-day chart is 59.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.76, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 38.52%. Stochastics %K at 82.46% indicates the stock is a selling.

How much short interest is there in Unity Software Inc.?

A steep rise in short interest was recorded in Unity Software Inc. stocks on Oct 13, 2022, dropping by -1.7 million shares to a total of 29.13 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 30.83 million shares. There was a decline of -5.84%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 13.72% of the overall stock float, the days-to-cover ratio (short ratio) fell to 4.21.

Unity Software Inc. [U] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 18,592,841 shares, or roughly 6.19% of the outstanding U shares. In other words, the investor’s shares have risen by 544,736 from its previous 13-F filing of 18048105.0. Additionally, ARK Investment Management LLC increased 22.75% of its stake after which the total value it holdings stand at $332,263,191, while BlackRock Fund Advisors added 4.85% of its stake to hold $221.74 million in the firm. Over the last quarter, Nikko Asset Management Co., Ltd. purchased 557,858 shares of Unity Software Inc., while Nikko Asset Management Americas, bought 553,459 shares. At present, SSgA Funds Management, Inc. is holding 4,195,258 shares valued at $123.76 million. Voya Investment Management Co. LL owned 3,883,572 shares of the company at the time of its most recent 13F filing, worth $114.57 million.

According to FactSet, Unity Software Inc.’s share price will average $34.90 in the next year, based on opinions of analysts polled by the firm. This is down nearly -12.07 percent from its previous closing price of $40.94. Analysts expect Unity Software Inc. stock to reach the higher price of $71.00, while the lowest price estimate is $16.00. However, 25 analysts have rated U stock as an Overweight in their predictions for 2022.

Recursion Pharmaceuticals Inc. (RXRX) may enjoy gains as insiders got busy in the recent days

Recursion Pharmaceuticals Inc.’s recent filing unveils that its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $23187.0 on Dec 01. In the deal valued at $9.27 per share,2,500 shares were sold. As a result of this transaction, Gibson Christopher now holds 0 shares worth roughly $0.0.

Then, Gibson Christopher sold 37,210 shares, generating $335,760 in total proceeds. Upon selling the shares at $9.02, the Chief Executive Officer now owns 582,805 shares.

Before that, Borgeson Blake sold 8,885 shares. Recursion Pharmaceuticals Inc. shares valued at $77,786 were divested by the Director at a price of $8.75 per share. As a result of the transaction, Borgeson Blake now holds 7,646,042 shares, worth roughly $69.66 million.

KeyBanc Capital Markets initiated its Recursion Pharmaceuticals Inc. [RXRX] rating to an Overweight in a research note published on Monday, September 16, 2022; the price target was $20. PT values the company’s stock at a premium of 54.45 to its Monday closing price. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in mid April from “a Buy” to “a Neutral”. SVB Leerink also remained covering RXRX and has decreased its forecast on March 04, 2022 with a “Mkt perform” recommendation from previously “an Outperform” rating. Berenberg started covering the stock on September 21, 2021. It rated RXRX as “a Buy”.

Price Performance Review of RXRX

On Monday, Recursion Pharmaceuticals Inc. [NASDAQ:RXRX] saw its stock fall -2.15% to $9.11. On the same session, the stock had its day’s lowest price of $8.97, but rose to a high of $9.42. Over the last five days, the stock has gained 8.71%. Recursion Pharmaceuticals Inc. shares have fallen nearly -46.82% since the year began. Nevertheless, the stocks have fallen -48.59% over the past one year. While a 52-week high of $21.19 was reached on 01/05/22, a 52-week low of $4.92 was recorded on 05/12/22. SMA at 50 days reached $10.47, while 200 days put it at $8.83. A total of 0.82 million shares were traded, compared to the trading of 0.72 million shares in the previous session.

Levels Of Support And Resistance For RXRX Stock

The 24-hour chart illustrates a support level at 8.91, which if violated will result in even more drops to 8.72. On the upside, there is a resistance level at 9.36. A further resistance level may holdings at 9.62. The Relative Strength Index (RSI) on the 14-day chart is 42.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.67%. Stochastics %K at 20.40% indicates the stock is a holding.

How much short interest is there in Recursion Pharmaceuticals Inc.?

A steep rise in short interest was recorded in Recursion Pharmaceuticals Inc. stocks on Oct 13, 2022, growing by 1.16 million shares to a total of 15.55 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 14.39 million shares. There was a rise of 7.46%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 13.23% of the overall stock float, the days-to-cover ratio (short ratio) rose to 11.19.

Recursion Pharmaceuticals Inc. [RXRX] – Who Are The Largest Shareholders?

In filings from Baillie Gifford & Co., it is revealed that the company now owns 21,594,693 shares, or roughly 13.08% of the outstanding RXRX shares. In other words, the investor’s shares have fallen by -10,992 from its previous 13-F filing of 21605685.0. Over the last quarter, The Vanguard Group, Inc. purchased 1,354,895 shares of Recursion Pharmaceuticals Inc., while Laurion Capital Management LP bought 0 shares. At present, SSgA Funds Management, Inc. is holding 4,555,759 shares valued at $48.06 million. Fidelity Management & Research Co owned 4,215,293 shares of the company at the time of its most recent 13F filing, worth $44.47 million.

According to FactSet, Recursion Pharmaceuticals Inc.’s share price will average $18.17 in the next year, based on opinions of analysts polled by the firm. This is up nearly 55.75 percent from its previous closing price of $9.31. Analysts expect Recursion Pharmaceuticals Inc. stock to reach the higher price of $42.00, while the lowest price estimate is $9.00. However, 6 analysts have rated RXRX stock as an Overweight in their predictions for 2022. The most recent change occurred on May 11, 2021 when SVB Leerink began covering the stock and recommended ‘”an Outperform”‘ rating along with a $33 price target.

The Potential Rise in the Price of Lantheus Holdings Inc. (LNTH) following insiders activity

0

In a filing, Lantheus Holdings Inc. revealed its Chief Operating Officer Blanchfield Paul unloaded Company’s shares for reported $0.13 million on Nov 17. In the deal valued at $54.79 per share,2,432 shares were sold. As a result of this transaction, Blanchfield Paul now holds 73,968 shares worth roughly $4.14 million.

Then, Sabens Andrea sold 386 shares, generating $22,774 in total proceeds. Upon selling the shares at $59.00, the Chief Accounting Officer now owns 61,618 shares.

Before that, Marshall Robert J. Jr. sold 5,000 shares. Lantheus Holdings Inc. shares valued at $295,000 were divested by the CFO and Treasurer at a price of $59.00 per share. As a result of the transaction, Marshall Robert J. Jr. now holds 121,065 shares, worth roughly $6.78 million.

SVB Leerink initiated its Lantheus Holdings Inc. [LNTH] rating to an Outperform in a research note published on Monday. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. B. Riley Securities began covering LNTH with “Buy” recommendation on May 09, 2022. Truist started covering the stock on April 13, 2022. It rated LNTH as “a Buy”.

Price Performance Review of LNTH

On Monday, Lantheus Holdings Inc. [NASDAQ:LNTH] saw its stock fall -8.58% to $56.01. On the same session, the stock had its day’s lowest price of $54.56, but rose to a high of $57.93. Over the last five days, the stock has lost -8.01%. Lantheus Holdings Inc. shares have risen nearly 93.87% since the year began. Nevertheless, the stocks have risen 111.36% over the past one year. While a 52-week high of $87.47 was reached on 09/14/22, a 52-week low of $23.51 was recorded on 01/28/22. SMA at 50 days reached $65.69, while 200 days put it at $65.68. A total of 4.08 million shares were traded, compared to the trading of 0.48 million shares in the previous session.

Levels Of Support And Resistance For LNTH Stock

The 24-hour chart illustrates a support level at 54.40, which if violated will result in even more drops to 52.80. On the upside, there is a resistance level at 57.77. A further resistance level may holdings at 59.54. The Relative Strength Index (RSI) on the 14-day chart is 38.06, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.77, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.89%. Stochastics %K at 60.62% indicates the stock is a holding.

How much short interest is there in Lantheus Holdings Inc.?

A steep rise in short interest was recorded in Lantheus Holdings Inc. stocks on Oct 13, 2022, growing by 0.74 million shares to a total of 3.73 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 2.99 million shares. There was a rise of 19.84%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 6.51% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.07.

Lantheus Holdings Inc. [LNTH] – Who Are The Largest Shareholders?

In filings from BlackRock Fund Advisors, it is revealed that the company now owns 9,975,082 shares, or roughly 14.51% of the outstanding LNTH shares. In other words, the investor’s shares have risen by 48,348 from its previous 13-F filing of 9926734.0. Additionally, The Vanguard Group, Inc. increased 4.31% of its stake after which the total value it holdings stand at $561,129,949, while AllianceBernstein LP added 2,826.51% of its stake to hold $200.08 million in the firm. Over the last quarter, SSgA Funds Management, Inc. purchased 1,425 shares of Lantheus Holdings Inc., while Lord, Abbett & Co. LLC bought 483,276 shares. At present, 1832 Asset Management LP is holding 1,765,400 shares valued at $130.62 million. Dimensional Fund Advisors LP owned 1,692,613 shares of the company at the time of its most recent 13F filing, worth $125.24 million.

According to FactSet, Lantheus Holdings Inc.’s share price will average $102.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 69.74 percent from its previous closing price of $61.27. Analysts expect Lantheus Holdings Inc. stock to reach the higher price of $120.00, while the lowest price estimate is $85.00. However, 7 analysts have rated LNTH stock as a Buy in their predictions for 2022. The most recent change occurred on February 01, 2021 when SVB Leerink began covering the stock and recommended ‘”an Outperform”‘ rating along with a $24 price target.

Monitoring CCC Intelligent Solutions Holdings Inc. (CCCS) after recent insider movements

CCC Intelligent Solutions Holdings Inc.’s filing revealed that its SVP, Chief Technology Officer GOODSON JOHN PAGE unloaded Company’s shares for reported $0.18 million on Nov 29. In the deal valued at $8.90 per share,20,000 shares were sold. As a result of this transaction, GOODSON JOHN PAGE now holds 15,435 shares worth roughly $0.13 million.

Then, GOODSON JOHN PAGE sold 20,000 shares, generating $186,028 in total proceeds. Upon selling the shares at $9.30, the SVP, Chief Technology Officer now owns 15,435 shares.

Before that, PRIGGE MARY JO sold 102,165 shares. CCC Intelligent Solutions Holdings Inc. shares valued at $939,244 were divested by the insider at a price of $9.19 per share. As a result of the transaction, PRIGGE MARY JO now holds 0 shares, worth roughly $0.0.

Barclays initiated its CCC Intelligent Solutions Holdings Inc. [CCCS] rating to an Equal weight in a research note published on Monday, October 21, 2022; the price target was $10. PT values the company’s stock at a premium of 12.6 to its Monday closing price. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early August with a ‘”a Neutral”‘ rating. Goldman also remained covering CCCS and has increased its forecast on July 13, 2022 with a “Buy” recommendation from previously “Neutral” rating. Jefferies started covering the stock on July 08, 2022. It rated CCCS as “a Buy”.

Price Performance Review of CCCS

On Monday, CCC Intelligent Solutions Holdings Inc. [NYSE:CCCS] saw its stock fall -4.48% to $8.74. On the same session, the stock had its day’s lowest price of $8.68, but rose to a high of $9.13. Over the last five days, the stock has lost -1.35%. CCC Intelligent Solutions Holdings Inc. shares have fallen nearly -23.27% since the year began. Nevertheless, the stocks have fallen -25.49% over the past one year. While a 52-week high of $12.64 was reached on 04/04/22, a 52-week low of $7.41 was recorded on 05/12/22. SMA at 50 days reached $8.95, while 200 days put it at $9.43. A total of 0.69 million shares were traded, compared to the trading of 0.52 million shares in the previous session.

Levels Of Support And Resistance For CCCS Stock

The 24-hour chart illustrates a support level at 8.57, which if violated will result in even more drops to 8.40. On the upside, there is a resistance level at 9.02. A further resistance level may holdings at 9.30. The Relative Strength Index (RSI) on the 14-day chart is 43.22, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.86%. Stochastics %K at 44.11% indicates the stock is a holding.

How much short interest is there in CCC Intelligent Solutions Holdings Inc.?

A steep rise in short interest was recorded in CCC Intelligent Solutions Holdings Inc. stocks on Oct 13, 2022, dropping by -0.11 million shares to a total of 4.15 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 4.26 million shares. There was a decline of -2.65%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.82% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.21.

CCC Intelligent Solutions Holdings Inc. [CCCS] – Who Are The Largest Shareholders?

In filings from T. Rowe Price Investment Manageme, it is revealed that the company now owns 29,756,018 shares, or roughly 4.80% of the outstanding CCCS shares. Additionally, The Vanguard Group, Inc. increased 7.61% of its stake after which the total value it holdings stand at $122,566,335, while Capital Research & Management Co reduced -0.45% of its stake to hold $89.94 million in the firm. Over the last quarter, Contour Asset Management LLC sold -232,057 shares of CCC Intelligent Solutions Holdings Inc., while Janus Henderson Investors US LLC sold 909,367 shares. At present, BlackRock Fund Advisors is holding 4,910,386 shares valued at $45.81 million. Vista Wealth Management Group LLC owned 4,725,000 shares of the company at the time of its most recent 13F filing, worth $44.08 million.

According to FactSet, CCC Intelligent Solutions Holdings Inc.’s share price will average $12.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 31.15 percent from its previous closing price of $9.15. Analysts expect CCC Intelligent Solutions Holdings Inc. stock to reach the higher price of $15.00, while the lowest price estimate is $10.00. However, 10 analysts have rated CCCS stock as an Overweight in their predictions for 2022. The most recent change occurred on June 03, 2022 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.

The Attractiveness of Investing In Bristol-Myers Squibb Company (BMY) is Growing

Bristol-Myers Squibb Company’s recently made public that its EVP, Chief Human Resources Powell Ann unloaded Company’s shares for reported $1.31 million on Nov 09. In the deal valued at $80.45 per share,16,250 shares were sold. As a result of this transaction, Powell Ann now holds 34,226 shares worth roughly $2.76 million.

Then, VESSEY RUPERT sold 45,910 shares, generating $3,621,381 in total proceeds. Upon selling the shares at $78.88, the EVP, Research & Early Dev. now owns 57,079 shares.

Before that, Caforio Giovanni sold 25,000 shares. Bristol-Myers Squibb Company shares valued at $1,742,750 were divested by the Board Chair and CEO at a price of $69.71 per share. As a result of the transaction, Caforio Giovanni now holds 476,104 shares, worth roughly $38.42 million.

Credit Suisse initiated its Bristol-Myers Squibb Company [BMY] rating to a Neutral in a research note published on Monday, November 18, 2022; the price target was $78. PT values the company’s stock at a premium of -3.46 to its Monday closing price. A number of analysts have revised their coverage, including Guggenheim’s analysts, who decreased its forecast for the stock in early October from “a Buy” to “a Neutral”. Berenberg also remained covering BMY and has decreased its forecast on September 14, 2022 with a “Hold” recommendation from previously “Buy” rating. Raymond James revised its rating on June 03, 2022. It rated BMY as “a Mkt perform” which previously was an “an Outperform”.

Price Performance Review of BMY

On Monday, Bristol-Myers Squibb Company [NYSE:BMY] saw its stock fall -0.53% to $80.70. On the same session, the stock had its day’s lowest price of $80.40, but rose to a high of $81.42. Over the last five days, the stock has gained 1.97%. Bristol-Myers Squibb Company shares have risen nearly 29.43% since the year began. Nevertheless, the stocks have risen 43.29% over the past one year. While a 52-week high of $81.43 was reached on 12/01/22, a 52-week low of $55.76 was recorded on 01/06/22. SMA at 50 days reached $75.01, while 200 days put it at $73.94. A total of 6.79 million shares were traded, compared to the trading of 6.37 million shares in the previous session.

Levels Of Support And Resistance For BMY Stock

The 24-hour chart illustrates a support level at 80.26, which if violated will result in even more drops to 79.82. On the upside, there is a resistance level at 81.28. A further resistance level may holdings at 81.86. The Relative Strength Index (RSI) on the 14-day chart is 67.93, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.02, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 11.91%. Stochastics %K at 91.69% indicates the stock is a selling.

How much short interest is there in Bristol-Myers Squibb Company?

A steep rise in short interest was recorded in Bristol-Myers Squibb Company stocks on Oct 13, 2022, dropping by 10000.0 shares to a total of 23.08 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 23.09 million shares. There was a decline of -0.04%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.08% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.27.

Bristol-Myers Squibb Company [BMY] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 190,967,096 shares, or roughly 8.98% of the outstanding BMY shares. In other words, the investor’s shares have risen by 3,030,385 from its previous 13-F filing of 187936711.0. Additionally, BlackRock Fund Advisors increased 2.03% of its stake after which the total value it holdings stand at $8,727,995,250, while SSgA Funds Management, Inc. reduced -0.65% of its stake to hold $7.15 billion in the firm. Over the last quarter, JPMorgan Investment Management, I purchased 536,756 shares of Bristol-Myers Squibb Company, while Capital Research & Management Co bought 14,298,520 shares. At present, Fidelity Management & Research Co is holding 51,599,491 shares valued at $4.0 billion. Geode Capital Management LLC owned 39,147,135 shares of the company at the time of its most recent 13F filing, worth $3.03 billion.

According to FactSet, Bristol-Myers Squibb Company’s share price will average $80.17 in the next year, based on opinions of analysts polled by the firm. This is up nearly 2.3 percent from its previous closing price of $81.13. Analysts expect Bristol-Myers Squibb Company stock to reach the higher price of $90.00, while the lowest price estimate is $60.00. However, 22 analysts have rated BMY stock as an Overweight in their predictions for 2022.

A Guide To The Risks Of Investing In Prime Medicine Inc. (PRME)

0

Prime Medicine Inc.’s recent filing unveils that its 10% Owner GV 2019 GP, L.L.C. acquired Company’s shares for reported $13.6 million on Oct 24. In the deal valued at $17.00 per share,800,000 shares were bought. As a result of this transaction, GV 2019 GP, L.L.C. now holds 11,522,248 shares worth roughly $210.17 million.

Then, NELSEN ROBERT bought 800,000 shares, generating $13,600,000 in total proceeds. Upon buying the shares at $17.00, the Director now owns 6,128,297 shares.

Before that, ARCH Venture Partners X, LLC bought 800,000 shares. Prime Medicine Inc. shares valued at $13,600,000 were divested by the 10% Owner at a price of $17.00 per share. As a result of the transaction, ARCH Venture Partners X, LLC now holds 6,128,297 shares, worth roughly $111.78 million.

Morgan Stanley initiated its Prime Medicine Inc. [PRME] rating to an Equal-weight in a research note published on Monday, November 14, 2022; the price target was $23. PT values the company’s stock at a premium of 20.7 to its Monday closing price. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in mid November with a ‘”an Overweight”‘ rating. Jefferies began covering PRME with “Buy” recommendation on November 14, 2022. Goldman started covering the stock on November 14, 2022. It rated PRME as “a Neutral”.

Price Performance Review of PRME

On Monday, Prime Medicine Inc. [NASDAQ:PRME] saw its stock jump 4.95% to $18.24. On the same session, the stock had its day’s lowest price of $15.75, but rose to a high of $18.93. Over the last five days, the stock has gained 4.59%. Prime Medicine Inc. shares have risen nearly 18.67% since the year began. A total of 0.74 million shares were traded, compared to the trading of 0.27 million shares in the previous session.

Levels Of Support And Resistance For PRME Stock

The 24-hour chart illustrates a support level at 16.35, which if violated will result in even more drops to 14.46. On the upside, there is a resistance level at 19.53. A further resistance level may holdings at 20.82. The Relative Strength Index (RSI) on the 14-day chart is 52.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.55%. Stochastics %K at 28.74% indicates the stock is a holding.

According to FactSet, Prime Medicine Inc.’s share price will average $24.25 in the next year, based on opinions of analysts polled by the firm. This is up nearly 38.09 percent from its previous closing price of $17.38. Analysts expect Prime Medicine Inc. stock to reach the higher price of $27.00, while the lowest price estimate is $22.00. However, 4 analysts have rated PRME stock as an Overweight in their predictions for 2022.

Taking a Closer Look At Verisk Analytics Inc. (VRSK) Following Its Recent Trade

In a filing, Verisk Analytics Inc. revealed its Director WRIGHT DAVID B unloaded Company’s shares for reported $0.73 million on Nov 30. In the deal valued at $182.88 per share,4,000 shares were sold. As a result of this transaction, WRIGHT DAVID B now holds 9,710 shares worth roughly $1.78 million.

Then, Vaughan Therese M sold 932 shares, generating $179,224 in total proceeds. Upon selling the shares at $192.30, the Director now owns 13,021 shares.

Before that, Beckles Kathy Card sold 429 shares. Verisk Analytics Inc. shares valued at $85,839 were divested by the EVP, Gen Counsel and Corp Sec at a price of $200.09 per share. As a result of the transaction, Beckles Kathy Card now holds 6,102 shares, worth roughly $1.12 million.

PT values the company’s stock at a premium of -7.74 to its Monday closing price. Deutsche Bank began covering VRSK with “Buy” recommendation on March 30, 2022.

Price Performance Review of VRSK

On Monday, Verisk Analytics Inc. [NASDAQ:VRSK] saw its stock fall -1.23% to $183.15. On the same session, the stock had its day’s lowest price of $182.10, but rose to a high of $184.01. Over the last five days, the stock has gained 3.16%. Verisk Analytics Inc. shares have fallen nearly -19.93% since the year began. Nevertheless, the stocks have fallen -17.37% over the past one year. While a 52-week high of $230.79 was reached on 01/03/22, a 52-week low of $156.05 was recorded on 06/16/22. SMA at 50 days reached $174.51, while 200 days put it at $185.11. A total of 0.86 million shares were traded, compared to the trading of 0.85 million shares in the previous session.

Levels Of Support And Resistance For VRSK Stock

The 24-hour chart illustrates a support level at 182.16, which if violated will result in even more drops to 181.18. On the upside, there is a resistance level at 184.07. A further resistance level may holdings at 185.00. The Relative Strength Index (RSI) on the 14-day chart is 56.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.65, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 22.80%. Stochastics %K at 86.06% indicates the stock is a selling.

How much short interest is there in Verisk Analytics Inc.?

A steep rise in short interest was recorded in Verisk Analytics Inc. stocks on Oct 13, 2022, dropping by -0.49 million shares to a total of 1.41 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 1.9 million shares. There was a decline of -34.75%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.01% of the overall stock float, the days-to-cover ratio (short ratio) fell to 1.86.

Verisk Analytics Inc. [VRSK] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 16,500,186 shares, or roughly 10.51% of the outstanding VRSK shares. In other words, the investor’s shares have risen by 78,148 from its previous 13-F filing of 16422038.0. Additionally, BlackRock Fund Advisors increased 0.71% of its stake after which the total value it holdings stand at $1,444,701,635, while Massachusetts Financial Services reduced -0.36% of its stake to hold $1.34 billion in the firm. Over the last quarter, SSgA Funds Management, Inc. sold -93,844 shares of Verisk Analytics Inc., while Parnassus Investments LLC sold 194,628 shares. At present, Geode Capital Management LLC is holding 3,674,214 shares valued at $671.76 million. Fidelity Management & Research Co owned 3,612,217 shares of the company at the time of its most recent 13F filing, worth $660.42 million.

According to FactSet, Verisk Analytics Inc.’s share price will average $189.80 in the next year, based on opinions of analysts polled by the firm. This is up nearly 2.46 percent from its previous closing price of $185.44. Analysts expect Verisk Analytics Inc. stock to reach the higher price of $220.00, while the lowest price estimate is $165.00. However, 17 analysts have rated VRSK stock as an Overweight in their predictions for 2022.

YELP (Yelp Inc.) may reap gains as insiders became active recently

0

Yelp Inc.’s filing revealed that its Chief Technology Officer Eaton Sam unloaded Company’s shares for reported $0.17 million on Nov 30. In the deal valued at $30.00 per share,5,547 shares were sold. As a result of this transaction, Eaton Sam now holds 180,726 shares worth roughly $5.3 million.

Then, Nachman Joseph R sold 6,000 shares, generating $175,410 in total proceeds. Upon selling the shares at $29.23, the Chief Operating Officer now owns 271,053 shares.

Before that, Schwarzbach David A sold 2,000 shares. Yelp Inc. shares valued at $62,200 were divested by the Chief Financial Officer at a price of $31.10 per share. As a result of the transaction, Schwarzbach David A now holds 185,172 shares, worth roughly $5.43 million.

Goldman downgraded its Yelp Inc. [YELP] rating to a Neutral from a a Buy in a research note published on Monday, July 15, 2022; the price target was decreased to $33 from $49. PT values the company’s stock at a premium of 11.12 to its Monday closing price. Evercore ISI also remained covering YELP and has decreased its forecast on April 06, 2021 with a “an In-line” recommendation from previously “an Outperform” rating. Citigroup revised its rating on March 30, 2021. It rated YELP as “a Buy” which previously was an “a Neutral”.

Price Performance Review of YELP

On Monday, Yelp Inc. [NYSE:YELP] saw its stock fall -2.98% to $29.33. On the same session, the stock had its day’s lowest price of $29.165, but rose to a high of $30.20. Over the last five days, the stock has gained 0.41%. Yelp Inc. shares have fallen nearly -19.07% since the year began. Nevertheless, the stocks have fallen -14.61% over the past one year. While a 52-week high of $39.26 was reached on 10/26/22, a 52-week low of $26.28 was recorded on 07/15/22. SMA at 50 days reached $33.51, while 200 days put it at $32.64. A total of 0.62 million shares were traded, compared to the trading of 0.78 million shares in the previous session.

Levels Of Support And Resistance For YELP Stock

The 24-hour chart illustrates a support level at 28.93, which if violated will result in even more drops to 28.53. On the upside, there is a resistance level at 29.97. A further resistance level may holdings at 30.60. The Relative Strength Index (RSI) on the 14-day chart is 37.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.20%. Stochastics %K at 53.24% indicates the stock is a holding.

How much short interest is there in Yelp Inc.?

A steep rise in short interest was recorded in Yelp Inc. stocks on Oct 13, 2022, dropping by -0.74 million shares to a total of 3.33 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 4.07 million shares. There was a decline of -22.22%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 6.45% of the overall stock float, the days-to-cover ratio (short ratio) fell to 5.13.

Yelp Inc. [YELP] – Who Are The Largest Shareholders?

In filings from BlackRock Fund Advisors, it is revealed that the company now owns 10,256,688 shares, or roughly 14.60% of the outstanding YELP shares. In other words, the investor’s shares have risen by 230,896 from its previous 13-F filing of 10025792.0. Additionally, The Vanguard Group, Inc. increased 6.88% of its stake after which the total value it holdings stand at $348,148,624, while Prescott Investors, Inc. reduced -1.88% of its stake to hold $120.46 million in the firm. Over the last quarter, Fisher Asset Management LLC sold -38,595 shares of Yelp Inc., while SSgA Funds Management, Inc. sold 123,355 shares. At present, Invesco Advisers, Inc. is holding 2,003,406 shares valued at $76.95 million. Tenzing Global Management LLC owned 2,000,000 shares of the company at the time of its most recent 13F filing, worth $76.82 million.

According to FactSet, Yelp Inc.’s share price will average $35.78 in the next year, based on opinions of analysts polled by the firm. This is up nearly 15.78 percent from its previous closing price of $30.23. Analysts expect Yelp Inc. stock to reach the higher price of $42.00, while the lowest price estimate is $30.00. However, 10 analysts have rated YELP stock as a Hold in their predictions for 2022.

An Analysis of Viavi Solutions Inc. (VIAV)’s Potential Price Growth

0

Viavi Solutions Inc.’s recently made public that its President & CEO KHAYKIN OLEG unloaded Company’s shares for reported $22080.0 on Dec 05. In the deal valued at $11.04 per share,2,000 shares were sold. As a result of this transaction, KHAYKIN OLEG now holds 897,613 shares worth roughly $9.77 million.

Then, KHAYKIN OLEG sold 19,475 shares, generating $217,146 in total proceeds. Upon selling the shares at $11.15, the President & CEO now owns 899,613 shares.

Before that, KHAYKIN OLEG sold 28,638 shares. Viavi Solutions Inc. shares valued at $326,187 were divested by the President & CEO at a price of $11.39 per share. As a result of the transaction, KHAYKIN OLEG now holds 919,088 shares, worth roughly $10.0 million.

Stifel initiated its Viavi Solutions Inc. [VIAV] rating to a Hold in a research note published on Monday, December 02, 2022; the price target was $12. PT values the company’s stock at a premium of 9.33 to its Monday closing price. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who decreased its forecast for the stock in early November from “a Buy” to “a Neutral”. Rosenblatt began covering VIAV with “Buy” recommendation on October 06, 2022. Needham revised its rating on July 19, 2022. It rated VIAV as “a Hold” which previously was an “a Buy”.

Price Performance Review of VIAV

On Monday, Viavi Solutions Inc. [NASDAQ:VIAV] saw its stock fall -2.42% to $10.88. On the same session, the stock had its day’s lowest price of $10.775, but rose to a high of $11.13. Over the last five days, the stock has lost -1.18%. Viavi Solutions Inc. shares have fallen nearly -38.25% since the year began. Nevertheless, the stocks have fallen -29.99% over the past one year. While a 52-week high of $18.14 was reached on 01/05/22, a 52-week low of $10.03 was recorded on 11/04/22. SMA at 50 days reached $12.73, while 200 days put it at $14.22. A total of 1.45 million shares were traded, compared to the trading of 1.96 million shares in the previous session.

Levels Of Support And Resistance For VIAV Stock

The 24-hour chart illustrates a support level at 10.73, which if violated will result in even more drops to 10.57. On the upside, there is a resistance level at 11.08. A further resistance level may holdings at 11.28. The Relative Strength Index (RSI) on the 14-day chart is 37.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.00%. Stochastics %K at 52.17% indicates the stock is a holding.

How much short interest is there in Viavi Solutions Inc.?

A steep rise in short interest was recorded in Viavi Solutions Inc. stocks on Oct 13, 2022, growing by 1.68 million shares to a total of 8.65 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 6.97 million shares. There was a rise of 19.42%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 5.37% of the overall stock float, the days-to-cover ratio (short ratio) rose to 5.44.

Viavi Solutions Inc. [VIAV] – Who Are The Largest Shareholders?

In filings from BlackRock Fund Advisors, it is revealed that the company now owns 33,607,692 shares, or roughly 14.81% of the outstanding VIAV shares. In other words, the investor’s shares have risen by 173,417 from its previous 13-F filing of 33434275.0. Additionally, The Vanguard Group, Inc. increased 1.49% of its stake after which the total value it holdings stand at $385,422,004, while Wellington Management Co. LLP reduced -30.98% of its stake to hold $210.75 million in the firm. Over the last quarter, Macquarie Investment Management B sold -176,922 shares of Viavi Solutions Inc., while Goldman Sachs Asset Management LP sold -193,125 shares. At present, SSgA Funds Management, Inc. is holding 8,001,866 shares valued at $120.83 million. Capital Research & Management Co owned 6,830,000 shares of the company at the time of its most recent 13F filing, worth $103.13 million.

According to FactSet, Viavi Solutions Inc.’s share price will average $14.36 in the next year, based on opinions of analysts polled by the firm. This is up nearly 32.29 percent from its previous closing price of $11.15. Analysts expect Viavi Solutions Inc. stock to reach the higher price of $16.00, while the lowest price estimate is $12.00. However, 10 analysts have rated VIAV stock as an Overweight in their predictions for 2022.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]